Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134753) titled 'A study on Lumican as a novel diagnostic biomarker for biliary atresia' on Oct. 20.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Shandong Provincial Hospital (Shandong Children's Hospital)
Condition:
Biliary Atresia and Liver Fibrosis
Intervention:
Case group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-08
Target Sample Size: Case group:20;Control group:15;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=340126
Disclaimer: Curated by HT Syndication....